Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
8th grade Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 2.8 Agreement and Plan of Merger
- 10.63 Change In Control Agreement
- 10.64 Change-in-control Agreement
- 10.65 Change-in-control Agreement
- 10.66 Amended and Restated Change-in-control Agreement
- 10.67 Amended and Restated Change-in-control Agreement
- 10.68 Amended and Restated Chage-in-control Agreement
- 10.69 Amended and Restated Change-in-control Agreement
- 10.70 Restated Stock Agreement
- 10.71 Restricted Stock Agreement
- 14.1 Invitrogen Protocol
- 21.1 List of Subsidiaries
- 23.1 Consent of Ernst & Young, LLP
- 31.1 Certification of Chief Executive Officer
- 31.2 Certification of Chief Financial Officer
- 32.1 Certification of Chief Executive Officer
- 32.2 Certification of Chief Financial Officer
aTyr Pharma similar filings
Filing view
External links